Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced two supply agreements for the COVID-19 Vaccine Moderna: one with the government of Taiwan for 5 million doses and another with the government of Colombia for 10 million doses.

Under the terms of the agreements, deliveries would begin in mid-2021. The COVID-19 Vaccine Moderna is not currently approved for use in Taiwan or Colombia, and the Company will work with regulators to pursue necessary approvals prior to distribution.

“We thank the governments of both Taiwan and Colombia for partnering with us to bring the COVID-19 Vaccine Moderna to Taiwan and Colombia. Both governments have moved quickly to get this done in the face of the pandemic and we appreciate their collaboration,” said Stéphane Bancel, Chief Executive Officer of Moderna.